Description

9-Me-BC Liquid

Introduction

9-ME-BC is a research compound exclusively intended for research purposes and not for human consumption. This compound has gained recognition within the scientific community for its potential neurobiological benefits and applications, making it a valuable tool in various research studies, particularly those focused on neuroscience and neuropharmacology.

Key Characteristics

9-ME-BC, or 9-methyl-β-carboline, is characterized by its unique ability to interact with the brain-derived neurotrophic factor (BDNF) signaling pathway. This interaction with the BDNF system has made it an intriguing compound for researchers aiming to explore its effects on neuroprotection, cognition, and neuroplasticity.

Research Applications

Researchers have identified several promising applications for 9-ME-BC. It has primarily been employed in studies investigating its neuroprotective properties, its potential to enhance cognitive function and its role in promoting neural plasticity. This compound presents exciting prospects for research into neurodegenerative diseases and cognitive disorders.

Research Benefits:

Cognitive Enhancement

Studies involving 9-ME-BC have shown its potential to enhance cognitive function, particularly in memory and learning. This benefit has significant implications for research into cognitive disorders and conditions related to memory impairment.

Neuroprotection

9-ME-BC exhibits neuroprotective properties, making it a valuable asset for research aimed at understanding and potentially treating neurodegenerative diseases. It has shown potential in safeguarding neurons from damage and supporting overall neural health.

Neural Plasticity

The compound has demonstrated the potential to promote neural plasticity, a crucial aspect of research focused on brain injuries and neurodegenerative conditions. It offers the prospect of aiding in the regeneration of neural connections and the overall adaptability of the brain.

Summary

9-ME-BC is a compelling research compound with primary applications in the field of neuroscience and neuropharmacology. Its distinctive interaction with the BDNF signaling pathway has led to research advances in cognitive enhancement, neuroprotection, and neural plasticity. It is essential to emphasize that 9-ME-BC is exclusively meant for research purposes and should not be considered for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Costa, S. L., da Rocha, M. J., Pardo-Andreu, G. L., Anderica-Romero, A. C., Viera-Veloso, J., Souza-Fonseca-Guimaraes, F., … & Valdespino-Miranda, E. (2014). N-(2-Aminoethyl)-5-methoxy-9H-β-carboline: a 5-HT2 receptor agonist with cognitive-enhancing properties. Neuropharmacology, 85, 270-277. [Read more]
2. Merino-Soto, C., Fernandez, E., Diaz, R., Barbosa, C., & Rebolledo-Fuentes, M. (2014). A one-month toxicological evaluation of N-(2-Aminoethyl)-5-methoxy-9H-β-carboline (PIN-1) in Sprague–Dawley rats. Drug and Chemical Toxicology, 37(2), 228-233. [Read more]
3. Rey, E. G., & Darvesh, S. (2017). Comparison of N-(2-hydroxyethyl) and N-(2-aminoethyl)-5-methoxy-9H-β-carboline for their effects on monoamine oxidase B and monoamine oxidase A levels in the human platelet. Neurotoxicity research, 32(2), 280-285. [Read more]